Dabigza 110 Capsule
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Dabigatran Etexilate (110mg)
Overview Dabigza 110 Capsule
Edoxaban 110mg capsules act as a blood thinner, preventing and treating blood clots. This medication lowers stroke and heart attack risk by inhibiting clot formation in leg, lung, brain, and heart veins. Frequently prescribed for patients with atrial fibrillation to prevent clots, it also benefits those post-knee or hip replacement surgery. It can be taken with or without food, but consistent daily timing is recommended. Long-term, even lifelong, use may be necessary; discontinuation or dosage changes require physician approval to avoid increased risk of stroke, heart attack, or thrombosis. Lifestyle modifications like quitting smoking, healthy eating, exercise, and weight management further reduce clotting risk. Common side effects include gastrointestinal upset and increased bleeding (nosebleeds, bruising). Report any side effects immediately. Other potential side effects include headaches, seizures, allergic reactions, visual changes, and fatigue. Contraindicated in individuals with severe kidney or liver disease, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR monitoring is unnecessary.
Uses of Dabigza 110 Capsule
Preventing and managing blood clots
Major Benefits of Dabigza 110 Capsule:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Dabigza 110 Capsules can be ingested with or without food; however, consistent daily timing is recommended.
Common Side effects of Dabigza 110 Capsule:
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Dabigza 110 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dabigza 110 Capsules. These capsules can be taken with or without food, although consistent timing is recommended.
How Dabigza 110 Capsule works:
Boehringer Ingelheim's Dabigatran etexilate 110 mg capsule is a new type of blood thinner. Its mechanism of action involves inhibiting clot development within the circulatory system.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dabigza 110 Capsule with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
Using Dabigatran 110mg capsules during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Dabigatran 110 mg capsules is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Dabigza 110 Capsules.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Dabigza 110 mg capsules; dosage modification may be necessary. A physician's consultation is advised. Dabigza 110 mg capsules are generally unsuitable for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Dabigatran 110 mg capsules cautiously. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Dabigza 110 Capsule :
Should you forget a Dabigza 110 Capsule dose, ingest it promptly that same day. However, omit the missed dose if it's impossible to administer it at least six hours prior to your next planned dose. Never compensate for a missed dose by taking a double dose.
Facts to Know About Dabigza 110 Capsule
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action class | Oral direct thrombin inhibitor |






